Authors
Latest:
The Five Things We Need to Do to Re-invent Commercial OperationsBy running Commercial Operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance
Latest:
Managing government pricing programsWhen state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences
Latest:
The Rising Importance of Observational ResearchInternational efforts to standardize guidelines for observational research could move the entire field forward
Latest:
3PL selection as part of product launch processThe importance of partners being flexible and optimizing their processes in today's virtual climate
Latest:
Specialty pharmacy accreditation — burden and benefitAccreditation status is both an entry ticket and a competitive measure for specialty pharmacies to attract manufacturer attention
Latest:
Digital opinion leaders (DOLs) and their role in pharma marketsLike traditional thinking about key opinion leaders (KOLs) in healthcare, consider the DOL as part of a marketing campaign
Latest:
Focusing pharma marketing on 'headroom'In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'
Latest:
Follow-on Biologics: A Patent Litigation PerspectiveIn whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully
Latest:
Managing quality risks across the pharmaceutical supply chainWell designed quality systems follow the product life cycle and foster a culture of quality
Latest:
Cold chain capacity crisis looms ahead of Covid-19 vaccine rollout. Are you prepared?Top players from cold chain logistics’ pharma, biologics, and life sciences sector sound alarm on the upcoming burden on temperature-controlled shipping capacity as the global supply chain plans for the safe distribution of Covid-19 vaccines requiring strict temperature management, some as cold as -20 to -30⁰C.
Latest:
Dealing With REMS Challenges in Drug CommercializationFive steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations
Latest:
To Market With GlaxoSmithKline Consumer Healthcare's Largest-Ever Product LaunchGSK worked with Kenco Logistic Services for a coordinated launch
Latest:
Navigating the patient journey after rare disease diagnosisCommercial teams can prepare for overcoming predictable hurdles
Latest:
Forecasting for the Pharmaceutical IndustryThe second edition of an essential business planner's library
Latest:
Strategies for effective patient services programsAddressing continued hurdles in patient adherence
Latest:
The current state of suspicious- order monitoringDEA’s manufacturer and distributor data-collection requirements are changing
Latest:
Feds Elevate Comparative Effectiveness to Address Future Healthcare DevelopmentEvaluating medicine and healthcare by their outcomes is now an NIH priority
Latest:
Laying the foundation for a national system for evidence generationSharing clinical data—EvGen—will improve both drug development and health outcomes analysis
Latest:
Complex supply chains demand a holistic approach to protect patientsThe USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity
Latest:
Look for Flexibility In Your CRM or SFA SystemBusiness, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?
Latest:
A new way to look at the performance of passive cold-chain shipping containersA 'performance curve' chart for containers could simplify the design process
Latest:
Vaccine growth spurs device, contract-services marketsA double-digit growth rate through 2024 means boom times for drug-delivery devices and for contract manufacturing services
Latest:
Meeting the challenges of rapid Covid-19 vaccine cold chain deploymentUltralow temperatures require a revision of vaccine distribution technology
